MasterSwitch Bio is developing a novel technology to treat fibrotic liver disease.
MasterSwitch Bio has raised $250K in total funding. The most recent round was Pre-Seed. The last funding was announced in June 2025.
MasterSwitch Bio's investors include Hatch Biofund Management.
MasterSwitch Bio is headquartered in Ambler, United States.
MasterSwitch Bio is developing a novel technology to treat fibrotic liver disease.
MasterSwitch Bio is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"MasterSwitch Bio — Funding & Investors." VCBacked, June 6, 2025, https://www.vcbacked.co/company/masterswitch-bio. Accessed July 27, 2026.
VCBacked. (2025). MasterSwitch Bio — Funding & Investors. Retrieved July 27, 2026, from https://www.vcbacked.co/company/masterswitch-bio
{{cite web |title=MasterSwitch Bio — Funding & Investors |url=https://www.vcbacked.co/company/masterswitch-bio |website=VCBacked |access-date=July 27, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated